Biogen Inc. buy Royal Bank of Canada
Start price
02.08.24
/
50%
€188.45
Target price
02.08.25
€267.50
Performance (%)
-39.72%
End price
03.08.25
€113.60
Summary
This prediction ended on 03.08.25 with a price of €113.60. Massive losses of -39.72% were the result for the BUY prediction by Royal_Bank_of_Canada. Royal_Bank_of_Canada has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -3.134% | -3.134% | -32.169% |
| iShares Core DAX® | 0.378% | -1.910% | 22.598% |
| iShares Nasdaq 100 | -0.117% | 3.610% | 16.621% |
| iShares Nikkei 225® | -0.806% | 4.615% | 6.119% |
| iShares S&P 500 | 0.059% | 2.263% | 11.549% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank of Canada from $282.00 to $292.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten